MetaADEDB 2.0 @ LMMD
pinaverium
(IKGXLCMLVINENI-UHFFFAOYSA-M)
Structure
SMILES
COc1cc(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)c(cc1OC)Br.[Br-]
Molecular Formula:
C26H41Br2NO4
Molecular Weight:
591.416
Log P:
2.2551
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
36.92
CAS Number(s):
53251-94-8
Synonym(s)
1.
pinaverium
2.
4-(6-bromoveratryl)-4-(2-(2-(6,6-dimethyl-2-norpinyl)ethoxy)ethyl)morpholinium bromide
3.
Dicetel
4.
Eldicet
5.
pinaverium bromide
External Link(s)
MeSHC013199
PubChem Compound40703
CHEMBLCHEMBL1909298
KEGGdr:D07094
Therapeutic Target DatabaseD0J1NQ
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainCanada Vigilance: 3Canada Vigilance
OFFSIDES
2Abdominal sepsisOFFSIDES
3Abnormal visionOFFSIDES
4Accidental exposure to productCanada Vigilance: 1Canada Vigilance
5AcidosisOFFSIDES
6AmnesiaOFFSIDES
7AnuriaOFFSIDES
8Aortic AneurysmOFFSIDES
9ApathyOFFSIDES
10AscitesOFFSIDES
11AtaxiaOFFSIDES
12AtelectasisOFFSIDES
13Atrial tachycardiaOFFSIDES
14Blood glucose decreasedOFFSIDES
15Blurred visionOFFSIDES
16Bronchoscopy abnormalOFFSIDES
17Cardiac valve vegetationOFFSIDES
18Choking sensationOFFSIDES
19Chronic ulcerative colitisOFFSIDES
20Clostridium colitisOFFSIDES
21ConfabulationOFFSIDES
22ConstipationCanada Vigilance: 1Canada Vigilance
23ContractureOFFSIDES
24Cytolytic hepatitisOFFSIDES
25DiarrheaOFFSIDES
26Disease ProgressionOFFSIDES
27Disseminated Intravascular CoagulationOFFSIDES
28DiverticulitisOFFSIDES
29DrowsinessOFFSIDES
30Drug administration errorOFFSIDES
31Drug exposure during pregnancyOFFSIDES
32Drug ineffectiveCanada Vigilance: 2Canada Vigilance
33Drug withdrawal headacheOFFSIDES
34DyspepsiaCanada Vigilance: 2Canada Vigilance
OFFSIDES
35DysuriaOFFSIDES
36Embolic strokeOFFSIDES
37EndocarditisOFFSIDES
38EpistaxisOFFSIDES
39ErythemaCanada Vigilance: 1Canada Vigilance
40GastroenteritisOFFSIDES
41Gastrointestinal motility disorderOFFSIDES
42HypersensitivityCanada Vigilance: 1Canada Vigilance
43Hypertrophic CardiomyopathyOFFSIDES
44HypoxiaOFFSIDES
45Infusion site mobility decreasedOFFSIDES
46Injection site urticariaOFFSIDES
47Intention tremorOFFSIDES
48Intestinal PerforationOFFSIDES
49Intestinal infarctionOFFSIDES
50Intestinal resectionOFFSIDES
51Kidney FailureOFFSIDES
52Leukopenia neonatalOFFSIDES
53Limb discomfortOFFSIDES
54Lung consolidationOFFSIDES
55MalaiseCanada Vigilance: 1Canada Vigilance
56Maternal exposure during pregnancyCanada Vigilance: 1Canada Vigilance
57Medication ErrorCanada Vigilance: 9Canada Vigilance
58Muscle WeaknessOFFSIDES
59MyelodysplasiaOFFSIDES
60NauseaCanada Vigilance: 2Canada Vigilance
61NephrolithiasisCanada Vigilance: 1Canada Vigilance
OFFSIDES
62Nervous tensionOFFSIDES
63Oropharyngeal painCanada Vigilance: 1Canada Vigilance
64OsteoporosisOFFSIDES
65OverdoseOFFSIDES
66PainCanada Vigilance: 1Canada Vigilance
67Post procedural bile leakOFFSIDES
68Pre-EclampsiaOFFSIDES
69Product intoleranceCanada Vigilance: 1Canada Vigilance
70PruritusCanada Vigilance: 1Canada Vigilance
71Septic ShockOFFSIDES
72Skin lesionOFFSIDES
73SomnolenceCanada Vigilance: 1Canada Vigilance
74SubileusOFFSIDES
75TinnitusOFFSIDES
76Umbilical herniaOFFSIDES
77Vaginal DischargeCanada Vigilance: 1Canada Vigilance
78VomitingCanada Vigilance: 1Canada Vigilance
79Vulvovaginal pruritusCanada Vigilance: 1Canada Vigilance
80Weight decreasedCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.